Previous Article | Next Article 
Molecular and Cellular Biology, November 2003, p. 7902-7908, Vol. 23, No. 21
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.21.7902-7908.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations
Johan W. Jonker, Els Wagenaar, Sven van Eijl, and Alfred H. Schinkel*
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Received 15 May 2003/
Returned for modification 21 July 2003/
Accepted 5 August 2003
The polyspecific organic cation transporters 1 and 2 (Oct1 and -2) transport a broad range of substrates, including drugs, toxins, and endogenous compounds. Their strategic localization in the basolateral membrane of epithelial cells in the liver, intestine (Oct1), and kidney (Oct1 and Oct2) suggests that they play an essential role in removing noxious compounds from the body. We previously showed that in Oct1-/- mice, the hepatic uptake and intestinal excretion of organic cations are greatly reduced. Since Oct1 and Oct2 have extensively overlapping substrate specificities, they might be functionally redundant. To investigate the pharmacologic and physiologic roles of these proteins, we generated Oct2 single-knockout and Oct1/2 double-knockout mice. Oct2-/- and Oct1/2-/- mice are viable and fertile and display no obvious phenotypic abnormalities. Absence of Oct2 in itself had little effect on the pharmacokinetics of tetraethylammonium (TEA), but in Oct1/2-/- mice, renal secretion of this compound was completely abolished, leaving only glomerular filtration as a TEA clearance mechanism. As a consequence, levels of TEA were substantially increased in the plasma of Oct1/2-/- mice. This study shows that Oct1 and Oct2 together are essential for renal secretion of (small) organic cations. A deficiency in these proteins may thus result in increased drug sensitivity and toxicity.
* Corresponding author. Mailing address: Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Phone: 31-20-5122046. Fax: 31-20-5122050. E-mail: a.schinkel{at}nki.nl.
Molecular and Cellular Biology, November 2003, p. 7902-7908, Vol. 23, No. 21
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.21.7902-7908.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Klaassen, C. D., Lu, H.
(2008). Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies. Toxicol Sci
101: 186-196
[Abstract]
[Full Text]
-
Maeda, T., Oyabu, M., Yotsumoto, T., Higashi, R., Nagata, K., Yamazoe, Y., Tamai, I.
(2007). Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats. Drug Metab. Dispos.
35: 1580-1586
[Abstract]
[Full Text]
-
Zhang, X., Cherrington, N. J., Wright, S. H.
(2007). Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. Am. J. Physiol. Renal Physiol.
293: F360-F370
[Abstract]
[Full Text]
-
Kang, H.-J., Song, I.-S., Shin, H. J., Kim, W.-Y., Lee, C.-H., Shim, J.-C., Zhou, H.-H., Lee, S. S., Shin, J.-G.
(2007). Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population. Drug Metab. Dispos.
35: 667-675
[Abstract]
[Full Text]
-
Vlaming, M. L. H., Mohrmann, K., Wagenaar, E., de Waart, D. R., Elferink, R. P. J. O., Lagas, J. S., van Tellingen, O., Vainchtein, L. D., Rosing, H., Beijnen, J. H., Schellens, J. H. M., Schinkel, A. H.
(2006). Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice. J. Pharmacol. Exp. Ther.
318: 319-327
[Abstract]
[Full Text]
-
Michel, V., Yuan, Z., Ramsubir, S., Bakovic, M.
(2006). Choline Transport for Phospholipid Synthesis.. Exp. Biol. Med.
231: 490-504
[Abstract]
[Full Text]
-
Saborowski, M., Kullak-Ublick, G. A., Eloranta, J. J.
(2006). The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4{alpha}. J. Pharmacol. Exp. Ther.
317: 778-785
[Abstract]
[Full Text]
-
Fullerton, M. D., Wagner, L., Yuan, Z., Bakovic, M.
(2006). Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. Am. J. Physiol. Cell Physiol.
290: C1230-C1238
[Abstract]
[Full Text]
-
Zhang, X., Shirahatti, N. V., Mahadevan, D., Wright, S. H.
(2005). A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2). J. Biol. Chem.
280: 34813-34822
[Abstract]
[Full Text]
-
Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., Sugiyama, Y.
(2005). A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters. J. Pharmacol. Exp. Ther.
315: 337-345
[Abstract]
[Full Text]
-
Bleasby, K., Hall, L. A., Perry, J. L., Mohrenweiser, H. W., Pritchard, J. B.
(2005). Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6). J. Pharmacol. Exp. Ther.
314: 923-931
[Abstract]
[Full Text]
-
Ishiguro, N., Saito, A., Yokoyama, K., Morikawa, M., Igarashi, T., Tamai, I.
(2005). TRANSPORT OF THE DOPAMINE D2 AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEY. Drug Metab. Dispos.
33: 495-499
[Abstract]
[Full Text]
-
Suhre, W. M., Ekins, S., Chang, C., Swaan, P. W., Wright, S. H.
(2005). Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2. Mol. Pharmacol.
67: 1067-1077
[Abstract]
[Full Text]
-
Kato, Y., Sai, Y., Yoshida, K., Watanabe, C., Hirata, T., Tsuji, A.
(2005). PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2. Mol. Pharmacol.
67: 734-743
[Abstract]
[Full Text]
-
Miakotina, O. L., Agassandian, M., Shi, L., Look, D. C., Mallampalli, R. K.
(2005). Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2. Am. J. Physiol. Lung Cell. Mol. Physiol.
288: L93-L102
[Abstract]
[Full Text]
-
Thomas, M. C., Tikellis, C., Kantharidis, P., Burns, W. C., Cooper, M. E., Forbes, J. M.
(2004). The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes. J. Pharmacol. Exp. Ther.
311: 456-466
[Abstract]
[Full Text]
-
Wright, S. H., Evans, K. K., Zhang, X., Cherrington, N. J., Sitar, D. S., Dantzler, W. H.
(2004). Functional map of TEA transport activity in isolated rabbit renal proximal tubules. Am. J. Physiol. Renal Physiol.
287: F442-F451
[Abstract]
[Full Text]
-
Wright, S. H., Dantzler, W. H.
(2004). Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport. Physiol. Rev.
84: 987-1049
[Abstract]
[Full Text]
-
Jonker, J. W., Schinkel, A. H.
(2004). Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3). J. Pharmacol. Exp. Ther.
308: 2-9
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.